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Abstract
Background: In this study, six enzyme-linked immunosorbent assays (ELISA), intended for routine porcine reproductive
and respiratory syndrome virus (PRRSV) herd monitoring, are tested for their ability to detect PRRSV specific antibodies
in the serum of pigs after vaccination with an inactivated PRRSV type 1 vaccine and subsequent infection with a highly
pathogenic (HP) PRRSV field strain. For this reason, ten piglets (group V) from a PRRSV negative herd were vaccinated
twice at the age of 2 and 4 weeks with an inactivated PRRSV vaccine. Ten additional piglets (group N) from the same
herd remained unvaccinated. Three weeks after second vaccination, each of the piglets received an intradermal
application of an HP PRRSV field strain. Serum samples were taken before first vaccination as well as before and
3, 7, 10 and 14 days after HP PRRSV application. All serum samples were tested for PRRSV RNA by reverse transcriptase
quantitative polymerase chain reaction (RT-qPCR) as well as for PRRSV antibodies with all six study ELISAs.
Results: At the beginning of the study (before vaccination), all of the piglets were PRRSV antibody negative with all
study ELISAs. They also tested negative for PRRSV RNA measured by RT-qPCR. From day 3 after HP PRRSV application
until the end of the study, a viremia was detected by RT-qPCR in all of the piglets. On day 0 (day of HP PRRSV
application), nine out of ten piglets of the pre-vaccinated group tested PRRSV antibody positive with one of the
tested ELISAs, although with lower S/P values than after infection. On day 10 after HP PRRSV application, all study
ELISAs except one had significantly higher S/P or OD values, respectively more positive samples, in group V than
in group N.
Conclusions: Only one of the tested ELISAs was able to detect reliably PRRSV antibodies in pigs vaccinated with
an inactivated PRRSV vaccine. With most of the tested ELISAs, higher S/P values respectively more positive samples
after PRRSV infection were seen in the pre-vaccinated group than in the non-vaccinated.
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Background
In studies validating or comparing new enzyme-linked
immunosorbent assays (ELISA) for the detection of anti-
bodies (Ab) against the porcine reproductive and re-
spiratory syndrome virus (PRRSV), the IDEXX PRRS X3
Ab test (IDEXX, Westbrook, USA) is usually used as the
gold standard [1–4]. This ELISA system has a sensitivity
of 98.8% and a specificity of 99.9%, according to manu-
facturer. In one study using serum samples collected
from challenged pigs, a sensitivity of 100% was found
[5]. Measured with the IDEXX ELISA, an antibody
response can be detected beginning between days 9 and
12 after PRRSV infection or vaccination with attenuated
PRRSV live vaccines [2, 6–9] and lasting at least until
day 120 after vaccination or challenge [10]. Although
the application of certain inactivated PRRSV vaccines
seems to prime the immune system and can, according
to some studies, lead to a faster and more effective
immune response after PRRSV infection [11, 12], no
antibody response has been observed with the IDEXX
ELISA after vaccination with inactivated PRRSV vaccines
[10, 13]. Therefore the question arises as to whether or
not other ELISAs are capable of detecting PRRSV spe-
cific Ab in the serum of pigs vaccinated with an inacti-
vated PRRSV vaccine. Studies conducted with a blocking
ELISA [2] and a commercial ELISA [14] hint towards
this possibility. In a study published by Cong et al. [2], a
combination of a nucleocapsid based ELISAs and an
ELISA based on non-structural proteins (NSP) as antigens
was even able to differentiate inactivated vaccine-derived
Ab from Ab evoked by live vaccines. The ELISAs
described in the study, however, are not commercially
available. For routine monitoring, new versions of
commercial ELISAs as well as some recently developed
ELISAs, based on the nucleocapsid or other antigens are
available or will soon be on the market.
The objective of the presented study was to evaluate if
commercial and/or newly developed PRRSV Ab ELISAs
are able to detect PRRSV Ab in the serum of pigs after
vaccination with an inactivated PRRSV type 1 vaccine.
Furthermore, the influence of the inactivated vaccination
on Ab development, measured with the respective ELISAs,
after subsequent intradermal application of a highly patho-
genic (HP) PRRSV field strain was compared with a
non-vaccinated group. Differences between the ELISAs
are emphasised.
Methods
Study design, animals and serum samples
The study included 20 piglets from a PRRSV free farm.
Ten piglets (group V) were pre-vaccinated twice at the
age of 2 and 4 weeks (days -33 and -19 of the study)
with an inactivated PRRSV vaccine in an oil-and-water ad-
juvant (2 ml i.m., Progressis, Merial, Batch No. L408629).
The other 10 piglets (group N) were not pre-vaccinated.
All 20 piglets received an intradermal application of 0.2 ml
of a HP PRRSV field strain (Vietnam_PRRSV_AGES/568-
30FC/13; GenBank accession number KM588915) diluted
in an adjuvant (Diluvac Forte, Intervet, Unterschleissheim,
Germany). Serum samples were taken directly before and
33 days after first vaccination (=day 0 of the study, directly
before HP PRRSV application) as well as 3, 7, 10 and
14 days after HP PRRSV application.
Molecular analysis
All serum samples were tested on each sampling point
with a commercial reverse transcriptase quantitative poly-
merase chain reaction (RT-qPCR) assay (TaqMan® NA
and EU PRRSV Reagents and Controls, ThermoFisher
Scientific, Vienna, Austria) for the presence of PRRSV
RNA as described previously [1].
Detection of PRRSV Ab by ELISA
The serum samples of all of the piglets at each sam-
pling point were tested for Ab against PRRSV by the
following ELISAs: a) IDEXX PRRS X3 Ab test – in the
following called IDEXX, b) INgezim PRRS 2.0 (Ingenasa,
Madrid, Spain) – INgezim, c) Civtest suis PRRS A/S plus
(Laboratorios HIPRA, Amer, Spain) – HIPRA A/S, d)
Civtest suis PRRS E/S plus (Laboratorios HIPRA) – HIPRA
E/S, e) pigtype® PRRSV Ab (QIAGEN, Leipzig, Germany) –
QIAGEN, f) PRRSV CHECK ELISA (Analytik Jena, aj
Roboscreen, Leipzig, Germany) – AJ.
All ELISAs were performed according to manufac-
turer’s instructions.
Statistical analysis
The results of the ELISAs measured in the serum samples
were described as positive or negative for PRRSV Ab.
Differences between the outcomes of the ELISAs at each
time point as well as differences between the groups for
each ELISA on each time point were calculated with the
Fisher’s exact test. The sensitivity of the ELISAs at each
sampling point and the 95% confidence interval using the
method of Clopper and Pearson were determined. The S/P
or OD values for each sampling point were shown in box-
plots using median, quartiles and 95% confidence interval.
S/P and OD values at each sampling point were tested for
normal distribution using the Kolmogorow-Smirnov test.
Since most parameters were not normally distributed,
differences between of the S/P or OD values in both groups
at each sampling point were determined with the Mann–
Whitney test. Differences between the S/P values of the
ELISAs on the sampling points before and after were tested
using the Friedman test followed by the Wilcoxon test as
post hoc test. A Bonferroni correction of the error of
probability was done. Differences with P < 0.05 were
considered significant.
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Results
Molecular analysis
Before vaccination with the inactivated vaccine in group
V as well as on day 0 (day of HP PRRSV application), all
of the serum samples from the piglets from both groups
tested negative by PRRSV RT-qPCR. On day 3 after HP
PRRSV application until the end of the study, all of the
piglets in the study tested positive by PRRSV RT-qPCR
as it was expected.
Detection of PRRSV antibodies by ELISA
At the beginning of the study (day -33), serum samples
from all of the piglets from both groups tested negative
in all of the study ELISAs. Tested by the INgezim
ELISA, nine out of ten piglets of group V and one out of
ten piglets of group N were PRRSV Ab positive on day
0. The number of PRRSV Ab positive piglets at each
sampling point is given in Table 1. The piglets from
group V remained Ab positive until day 14 with the
INgezim ELISA with significantly higher S/P values on
days 10 and 14 than on days 0 and 3. Significant differ-
ences between the ELISAs regarding the number of
positive piglets at each sampling day are indicated in
Table 1. The sensitivity of the ELISAs at each time point
can be seen in Table 2. Figure 1 shows the S/P and OD
values of each ELISA at the different sampling points.
Measured with INgezim ELISA, the S/P values in group
V were significantly higher than in group N on days 0, 3,
7, and 10. With the HIPRA A/S, group V had
significantly higher S/P values than group N on days 0, 7
and 10, although fewer samples were Ab positive than in
the other ELISAs. Significantly higher S/P values in
group V on days 10 and 14 were also found with the
HIPRA E/S with two positive piglets on both sampling
points. With the AJ ELISA, significant differences be-
tween the groups were seen on days 0, 7 and 10 with
higher S/P values in group V resulting in two positive
samples in group V on day 7. Significantly more piglets
from group V were positive on day 10, tested with the
HIPRA A/S and the AJ ELISA than in group N. The
IDEXX and QIAGEN ELISAs showed no significant
differences in S/P values between group V and N,
although a tendency in higher S/P values in group V was
seen in the QIAGEN ELISA on day 10 (Fig. 1) with a
tendency of more positive samples in group V than in
group N (Table 1).
Discussion
This study tested the ability of six ELISAs for detection
of PRRSV Ab after inactivated vaccination of piglets and
subsequent infection with HP PRRSV. Data are
published about the performance, sensitivity and specifi-
city of the ELISAs tested in this study [1, 6, 15, 16]. They
did, however, not concern serum of pigs vaccinated with
an inactivated vaccine. Therefore, this aspect was
illuminated in this study.
The nucleocapsid-based IDEXX PRRS X3 Ab test is
usually used as the gold standard for detection of PRRSV
Ab by ELISA [1–4]. In our study, with this ELISA, how-
ever, no Ab could be detected in serum samples of
piglets vaccinated with an inactivated vaccine. This con-
firms the findings of another study, where no antibody
response was detected with the IDEXX ELISA after inac-
tivated PRRSV vaccination as well [10]. As expected
from the results of other studies [2, 6, 16], the IDEXX
ELISA tested most piglets PRRSV Ab positive from day
10 after infection onwards. According to a study by
Zuckermann et al., the IDEXX ELISA was able to detect
higher S/P values in pigs pre-vaccinated with an inacti-
vated PRRSV vaccine than in non-vaccinated pigs on
days 7 and 10 after the subsequent challenge [13]. In our
study, however, no differences were found between
vaccinated and non-vaccinated piglets with the IDEXX
ELISA. In contrast to the IDEXX ELISA, some of the
other tested ELISAs were able to detect PRRSV Ab in
piglets vaccinated with the inactivated vaccine. An espe-
cially high sensitivity in this respect was found in the
similarly nucleocapsid-based INgezim ELISA that tested
most of the samples from the vaccinated piglets PRRSV
Ab positive. This confirms the results of a previously
published study that describes the ability of a former
version of an ELISA produced by Ingenasa to detect
PRRSV Ab after inactivated vaccination of pigs [14]. The
Table 1 Results of PRRSV Ab ELISAs at the sampling points,
number of positive animals
Study day -33 0 3 7 10 14
n = 10 n = 10 n = 10 n = 10 n = 10 n = 10
Group V
IDEXX 0 0b 0b 0b 8a,b 10a
INgezim 0 9a 7a 10a 10a 10a
HIPRA A/S 0 2b 2b 1b 5b 5b
HIPRA E/S 0 0b 0b 0b 2c 2c
QIAGEN 0 0b 0b 0b 8a,b 10a
AJ 0 0b 0b 2b 7a,b 8a,b
Group N
IDEXX 0 0 0 0 7b,c 9a
INgezim 0 1 0 0 10a,b 10a
HIPRA A/S 0 0 0 0 0c 3b,c
HIPRA E/S 0 0 0 0 0c 0c
QIAGEN 0 0 0 0 4c 9a
AJ 0 0 0 0 1c 6a,b
Group V: vaccination with an inactivated PRRSV type 1 vaccine on days -33
and -19
Groups V and N: intradermal application of an HP PRRSV field strain on day 0
Different letters indicate significant differences between the ELISAs in each
group on each sampling point
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Table 2 Sensitivity (%) of PRRSV Ab ELISAs at each sampling point (95% confidence interval)
Study day 0 3 7 10 14
Group V
IDEXX 0 (0–30) 0 (0–30) 0 (0–30) 80 (44–98) 100 (69–100)
INgezim 90 (60–98) 70 (35–93) 100 (69–100) 100 (69–100) 100 (69–100)
HIPRA A/S 20 (3–56) 20 (3–56) 10 (0–45) 50 (19–81) 50 (19–81)
HIPRA E/S 0 (0–30) 0 (0–30) 0 (0–30) 20 (3–56) 20 (3–56)
QIAGEN 0 (0–30) 0 (0–30) 0 (0–30) 80 (44–98) 100 (69–100)
AJ 0 (0–30) 0 (0–30) 20 (3–56) 70 (35–93) 80 (44–98)
Group N
IDEXX n.d. 0 (0–30) 0 (0–30) 70 (35–93) 90 (60–98)
INgezim n.d. 0 (0–30) 0 (0–30) 100 (69–100) 100 (69–100)
HIPRA A/S n.d. 0 (0–30) 0 (0–30) 0 (0–0) 30 (7–65)
HIPRA E/S n.d. 0 (0–30) 0 (0–30) 0 (0–0) 0 (0–0)
QIAGEN n.d. 0 (0–30) 0 (0–30) 40 (12–74) 90 (60–98)
AJ n.d. 0 (0–30) 0 (0–30) 10 (0–45) 60 (26–88)
Group V: vaccination with an inactivated PRRSV type 1 vaccine on days -33 and -19
Groups V and N: intradermal application of an HP PRRSV field strain on day 0
n.d. not done
Fig. 1 Boxplots of S/P values, respectively OD values of all tested PRRSV Ab ELISAs. Vaccinated group: vaccination with an inactivated PRRSV type
1 vaccine on days -33 and -19 (see arrows), both groups: intradermal application of an HP PRRSV field strain on day 0 (see arrows). Red lines: cut-off of
the ELISAs. The black triangle indicates significant differences between the groups
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S/P values seen in the INgezim ELISA after inactivated
vaccination were significantly lower than on days 10 and
14 after HP PRRSV application. Low PRRSV Ab S/P
values detected with the INgezim ELISA in groups of
piglets from PRRSV negative farms can be a sign for
inactivated PRRSV vaccination, especially when no
antibodies can be found with the IDEXX or another of
the tested ELISAs. A reliable differentiation between
vaccinated and infected pigs, however, is not possible.
One positive result was found with the INgezim ELISA
in the non-vaccinated group at day 0. The specificity of
this ELISA was calculated with 99% in another study,
which is slightly lower than the specificity of the IDEXX
ELISA [1]. This can be the explanation for the false posi-
tive result. The specificities of the other tested ELISAs
have been calculated in the mentioned study as well [1].
With the HIPRA A/S ELISA that is based on mem-
brane glycoproteins and in the AJ ELISA, based on a
mixture of structural proteins, including the nucleocap-
sid, on day 10 significantly more samples were tested
positive in group V than in group N. In tendency, more
vaccinated piglets were Ab positive on day 10 tested
with the QIAGEN ELISA. This would, however, not
allow a differentiation between vaccinated and non-
vaccinated pigs after PRRSV infection, since the ELISAs
are not quantitative, but give only qualitative results.
With the INgezim ELISA, significantly more piglets
were tested positive from days 3 to day 14 in group V
and on days 10 and 14 in group N than with most of the
other ELISAs which goes confirm with the calculated
sensitivity of this ELISA. The sensitivity of the ELISAs at
each time point was highest in the nucleocapsid based
ELISAs, especially in the INgezim ELISA. Lower sensi-
tivities were found with the HIPRA ELISAs and the AJ
ELISA. For both of them, a later onset of Ab detection
than for the nucleocapsid based ELISAs has been
described in another study and is due to the antigen
used in the ELISAs [16].
The adding of an adjuvant and the intradermal adminis-
tration route of the HP PRRSV virus was used to induce a
strong Ab response detectable by the ELISAs. An adjuvant
as it was used for the challenge strain in this study is able
to enhance Ab production to a certain degree without a
vaccine [10]. Intradermal application of a modified live vac-
cine was shown to elicit an effective immune response [17].
It cannot be concluded from the results of our study if
the development of a protective immunity after infection
would be enhanced in the vaccinated piglets. Some studies
are available that refer to protective immune response after
vaccination against PRRSV with a novel killed vaccine
[11, 12]. Another study used a killed PRRSV vaccine in
previously infected pigs which resulted in increased serum
neutralization Ab titers and interferon γ producing cells,
although the virus shedding was not affected [18]. Other
studies did not show killed vaccines to have any protective
effect including the one used in this study [2, 14].
The inactivated PRRS vaccine used in group V belongs
to the same subgroup of type 1 as the Lelystad strain
with 99% homology to this strain [11]. This was confirmed
in our laboratory as well (data not shown). Although the
HIPRA A/S ELISA claims to detect PRRSV type 2 anti-
bodies exclusively, the S/P values in serum of the pigs from
group V treated with an inactivated PRRSV type 1 vaccine
were significantly higher than in the non-vaccinated pig-
lets. The HIPRA E/S, on the other hand, reacted only
slightly. This indicates some cross reactions between
PRRSV type 1 and 2 Ab, detected with the HIPRA ELISAs.
These cross reactions were seen in another study as well
[16] and are also acknowledged by the manufacturer.
Conclusions
This study showed that, among the tested ELISAs, only
the INgezim ELISA was able to detect an Ab develop-
ment in most of the piglets after inactivated PRRS vac-
cination and before the infection with HP PRRSV field
strain, although with lower S/P values than after the
infection. This ELISA can therefore be used to detect Ab
in PRRSV negative pigs vaccinated with an inactivated
PRRS vaccine. Five of the six tested ELISAs, based on
nucleocapsid, such as the INgezim and QIAGEN ELISAs,
or other antigens, as in the HIPRA and AJ ELISAs, are
able to show a difference in Ab development between pig-
lets vaccinated with an inactivated vaccine and subsequent
HP PRRSV application and piglet not pre-vaccinated
before HP PRRSV application. These differences were not
seen when using the IDEXX ELISA. The HIPRA A/S plus
ELISA is able to detect exclusively PRRSV type 2 Ab,
although some cross reactions with PRRSV type 1 Ab
are expected. The different characteristics and perform-
ance of the available test systems have to be considered
when choosing an ELISA for PRRSV monitoring in pig
herds.
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